Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVETIRACETAM for Tuberous sclerosis complex: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 26 adverse event reports in the FDA FAERS database where LEVETIRACETAM was used for Tuberous sclerosis complex.

Most Reported Side Effects for LEVETIRACETAM

Side Effect Reports % Deaths Hosp.
Seizure 9,961 15.9% 272 2,972
Drug ineffective 8,666 13.9% 477 2,692
Off label use 5,789 9.3% 456 2,040
Maternal exposure during pregnancy 3,197 5.1% 85 321
Foetal exposure during pregnancy 2,604 4.2% 146 331
Epilepsy 2,546 4.1% 86 794
Generalised tonic-clonic seizure 2,276 3.6% 55 688
Somnolence 2,070 3.3% 77 770
Fatigue 1,972 3.2% 31 525
Status epilepticus 1,883 3.0% 210 949
Dizziness 1,592 2.6% 22 530
Condition aggravated 1,508 2.4% 127 579
Drug interaction 1,443 2.3% 101 606
Abortion spontaneous 1,392 2.2% 6 20
Aggression 1,381 2.2% 20 413

Other Indications for LEVETIRACETAM

Epilepsy (17,599) Product used for unknown indication (14,265) Seizure (12,072) Partial seizures (2,926) Generalised tonic-clonic seizure (2,753) Status epilepticus (2,650) Off label use (2,161) Seizure prophylaxis (942) Focal dyscognitive seizures (491) Petit mal epilepsy (412)

Other Drugs Used for Tuberous sclerosis complex

EVEROLIMUS (482) VIGABATRIN (303) CANNABIDIOL (241) SIROLIMUS (131) LAMOTRIGINE (29) TOPIRAMATE (29) LACOSAMIDE (19) OXCARBAZEPINE (19) VALPROIC ACID (19) CARBAMAZEPINE (15)

Related Pages

LEVETIRACETAM Full Profile All Tuberous sclerosis complex Drugs LEVETIRACETAM Demographics LEVETIRACETAM Timeline